Loading organizations...
Loading organizations...
Biotechnology company focused on neurodegenerative disease diagnostics and
APRINOIA Therapeutics has raised $11.1M across 1 funding round.
APRINOIA Therapeutics has raised $11.1M in total across 1 funding round.
APRINOIA Therapeutics has raised $11.1M in total across 1 funding round.
APRINOIA Therapeutics's investors include Daiwa Corporate Investment, Kevin Kuk-Hyun Kyung, ShangPharma Investment Group, Taian Venture Capital.
APRINOIA Therapeutics has raised $11.1M across 1 funding round. Most recently, it raised $11.1M Series B in January 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 16, 2018 | $11.1M Series B | Daiwa Corporate Investment, Kevin Kuk-Hyun Kyung | ShangPharma Investment Group, Taian Venture Capital |